NN Trading Analysis - 10/02/2026 02:07 PM — TRU-SENTIMENT

News Headlines & Context:

The following items are provided from general knowledge for contextual background only and are not derived from the embedded market data:

• NN (Neuronetics, Inc.) announced earlier in 2026 a strategic pivot toward expanded neurology device pipelines, though profitability remains elusive with negative EPS.
• Recent sector coverage suggested small-cap med-tech names faced reimbursement pressure, potentially weighing on NN's revenue visibility.
• No confirmed near-term earnings date was flagged in the provided data; fiscal year end is listed as 2025-12-01 in fundamentals.
• Low institutional ownership (16.71%) indicates retail-driven flow may amplify volatility.
• Options sentiment turned abruptly bullish in early October despite weak technicals, possibly on speculative positioning rather than fundamental news.

Context: Headlines suggest a fundamentally challenged company, which contrasts with the bullish options flow seen in the embedded True Sentiment data. This divergence is addressed in the data-driven sections below.

Fundamental Analysis:

Based strictly on the embedded FUNDAMENTALS data for NN:

• Trailing EPS is -0.82; company is unprofitable with no positive earnings trend available.
• Trailing P/E is null and Forward P/E is null; PEG ratio is null — valuation via earnings multiples is not calculable.
• Profit margins, revenue growth, ROE, Debt/Equity, and Free Cash Flow are all null — key strength/weakness metrics unavailable.
• Dividend yield is 0.00%; no income component.
• Market cap is $2,415,671,100.00 with shares outstanding of 168,810,000.00.
• Institutional percent is 16.71% — low institutional sponsorship.
• 52-week high $24.42, low $10.87; current price near lower third of range.
• Beta is 0.24 (low systemic risk); historical volatility 60.91% (high idiosyncratic vol).
• Analyst consensus, target mean price, and number of opinions are null — no street forecast embedded.

Fundamentals show a loss-making small cap with sparse disclosure, diverging from the bullish options sentiment but aligning with bearish technicals (price below SMAs, negative MACD).

Current Market Position:

From daily history and minute bars: Current price as of 2026-10-01 close is $13.93 (indicators current_price). Minute bars show 2026-10-02 13:35 close $14.33, up from 09:30 open $14.43 to intraday low $13.75 on 10-01. Recent daily action: 09-29 close $13.96, 09-30 $14.49, 10-01 $13.93 — choppy.

Key levels from data: 30-day low $13.55, high $18.75; Bollinger lower $13.74, upper $15.93; daily low 10-01 $13.75. Resistance: SMA20 $14.83, SMA50 $15.37.

Intraday momentum: From 10-01 09:30 $14.43 to 13:35 10-02 $14.33, with last 5 bars upward (14.26→14.35→14.33). Volume on 10-02 13:35 was 18,878 — mild recovery.

Technical Analysis:

SMA alignment: Price $13.93 below SMA5 $14.20, SMA20 $14.83, SMA50 $15.37 — bearish stack (50>20>5>price). No golden cross; prior death stack intact. RSI 40.56 under 50 = bearish momentum but not oversold. MACD -0.43 < signal -0.34, hist -0.09 = bearish. Bollinger: price near lower band $13.74, no squeeze (bands $13.74–$15.93). 30-d range $13.55–$18.75: price at 4.6% from low. Range context: near 30d bottom.

True Sentiment Analysis (Delta 40-60 Options):

From True Sentiment Options data (methodology: Delta 40-60 only):

Call Volume: $1,005,285.00 (85.80%) Put Volume: $166,505.00 (14.20%) Total: $1,171,790.00

Sentiment: Bullish (call contracts 5,139 vs put 179; call trades 14 vs put 8). Pure directional conviction heavily call-sided. Near-term expectations: upside speculative bets. Divergence: Option spread recommendations show "Divergence detected between technical indicators and options sentiment" — technicals bearish, sentiment bullish. This is the only sentiment source; no X posts used.

Key Price Levels (observational only):